NeuroSense bolsters case for multi-target Alzheimer’s strategy

Biomarker results suggest PrimeC may be acting on shared neurodegeneration mechanisms, adding weight to growing shift in brain aging research. What if ALS, Alzheimer’s and Parkinson’s aren’t entirely separate diseases after all? Isn’t it that, for many years, we have treated neurodegenerative disorders as distinct conditions, each with its own causes, symptoms and treatment strategies? […] The post NeuroSense bolsters case for multi-target Alzheimer’s strategy appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.